Zhang L - Search Results

1

Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.

Yu PC, Tan LC, Zhu XL, Shi X, Chernikov R, Semenov A, Zhang L, Ma B, Wang Y, Zhou XY, Ji QH, Wei WJ, Wang YL. Yu PC, et al. Among authors: zhang l. Endocr Pract. 2021 Jul;27(7):698-705. doi: 10.1016/j.eprac.2021.01.015. Epub 2021 Jan 27. Endocr Pract. 2021. PMID: 33515759

2

Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.

Cao YM, Gu J, Zhang YS, Wei WJ, Qu N, Wen D, Liao T, Shi RL, Zhang L, Ji QH, Wang Y, Sun GH, Zhao YX, Wang YJ, Yu J, Zhu YX. Cao YM, et al. Among authors: zhang l, zhang ys. Oncol Rep. 2018 Jan;39(1):338-348. doi: 10.3892/or.2017.6058. Epub 2017 Oct 25. Oncol Rep. 2018. PMID: 29115628

3

Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules.

Tan LC, Liu WL, Zhu XL, Yu PC, Shi X, Han PZ, Zhang L, Lin LY, Semenov A, Wang Y, Ji QH, Ji DM, Wang YL, Qu N. Tan LC, et al. Among authors: zhang l. Front Oncol. 2021 Jul 12;11:677892. doi: 10.3389/fonc.2021.677892. eCollection 2021. Front Oncol. 2021. PMID: 34322384 Free PMC article.

4

BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center.

Ren M, Zhang J, Kong Y, Bai Q, Qi P, Zhang L, Wang Q, Zhou X, Chen Y, Zhu X. Ren M, et al. Among authors: zhang l, zhang j. Ann Transl Med. 2022 Jan;10(2):31. doi: 10.21037/atm-21-4235. Ann Transl Med. 2022. PMID: 35282092 Free PMC article.

5

Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.

Zhang X, Xu Y, He C, Guo X, Zhang J, He C, Zhang L, Kong M, Chen B, Zhu C. Zhang X, et al. Among authors: zhang l, zhang j. J Surg Oncol. 2015 Jun;111(7):834-9. doi: 10.1002/jso.23888. J Surg Oncol. 2015. PMID: 25919911

6

MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

Yang B, Liu H, Bi Y, Cheng C, Li G, Kong P, Zhang L, Shi R, Zhang Y, Zhang R, Cheng X. Yang B, et al. Among authors: zhang l, zhang r, zhang y. Int J Med Sci. 2020 Jul 25;17(13):2013-2023. doi: 10.7150/ijms.46234. eCollection 2020. Int J Med Sci. 2020. PMID: 32788880 Free PMC article.

7

Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.

Cui Y, Chen H, Xi R, Cui H, Zhao Y, Xu E, Yan T, Lu X, Huang F, Kong P, Li Y, Zhu X, Wang J, Zhu W, Wang J, Ma Y, Zhou Y, Guo S, Zhang L, Liu Y, Wang B, Xi Y, Sun R, Yu X, Zhai Y, Wang F, Yang J, Yang B, Cheng C, Liu J, Song B, Li H, Wang Y, Zhang Y, Cheng X, Zhan Q, Li Y, Liu Z. Cui Y, et al. Among authors: zhang l, zhang y. Cell Res. 2020 Oct;30(10):902-913. doi: 10.1038/s41422-020-0333-6. Epub 2020 May 12. Cell Res. 2020. PMID: 32398863 Free PMC article.

8

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.

Liu S, Wang Y, Han Y, Xia W, Zhang L, Xu S, Ju H, Zhang X, Ren G, Liu L, Ye W, Zhang Z, Hu J. Liu S, et al. Among authors: zhang l, zhang z, zhang x. Theranostics. 2020 Aug 25;10(23):10589-10605. doi: 10.7150/thno.47176. eCollection 2020. Theranostics. 2020. PMID: 32929368 Free PMC article.

9

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial.

Xu J, Shen J, Gu S, Zhang Y, Wu L, Wu J, Shao G, Zhang Y, Xu L, Yin T, Liu J, Ren Z, Xiong J, Mao X, Zhang L, Yang J, Li L, Chen X, Wang Z, Gu K, Chen X, Pan Z, Ma K, Zhou X, Yu Z, Li E, Yin G, Zhang X, Wang S, Wang Q. Xu J, et al. Among authors: zhang l, zhang x, zhang y. Clin Cancer Res. 2021 Feb 15;27(4):1003-1011. doi: 10.1158/1078-0432.CCR-20-2571. Epub 2020 Oct 21. Clin Cancer Res. 2021. PMID: 33087333 Clinical Trial.

10

Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms.

Klingler S, Guo B, Yao J, Yan H, Zhang L, Vaseva AV, Chen S, Canoll P, Horner JW, Wang YA, Paik JH, Ying H, Zheng H. Klingler S, et al. Among authors: zhang l. Cancer Res. 2015 May 15;75(10):2109-19. doi: 10.1158/0008-5472.CAN-14-3122. Epub 2015 Mar 25. Cancer Res. 2015. PMID: 25808866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125,990 results

Search Page